Association of HLA-DRB1 Alleles with Rheumatic Fever and Rheumatic Heart Disease: A Meta-analysis.

BACKGROUND

Rheumatic fever (RF) and its sequel rheumatic heart disease (RHD) is an autoimmune disease caused by an abnormal host immune response to group A streptococcus (GAS) infection. The HLA class II molecules are entailed in immune-mediated infectious, inflammatory, and autoimmune diseases including RHD. However, HLA class II genes are reported to be associated with RF/RHD across different populations with a very little consistency.

OBJECTIVE

The aim of the study is to investigate the association between HLA class II genes and RF/RHD by meta-analysis.

METHODS

A comprehensive literature search was conducted to identify all relevant case-control studies published before December 31, 2019. The data were extracted using standardized form and pooled odds ratio (OR) with 95% confidence interval (CI) are calculated to assess the strength of the association between HLA class II genes and RF/RHD.

RESULTS

Thirteen studies for HLA-DRB1 alleles (1065 patients and 1691 controls) and eight studies for HLA-DQB1 alleles (644 patients and 1088 controls) were finally included. The meta-analysis showed a significantly higher frequency of HLA-DRB107 allele (OR = 1.68, < .0001) in RF/RHD patients when compared to controls, while the frequency of HLA-DRB115 allele (OR = 0.60, = .03) was significantly lower in RF/RHD patients than in controls. However, there were no significant differences in the frequency of HLA-DQB1 alleles between RF/RHD patients and controls.

CONCLUSIONS

The results of the meta-analysis suggest that the differential presentation of autoimmune peptides by HLA-DRB107 (susceptible) and HLA-DRB115 (protective) alleles with different affinities may play a crucial role in the pathogenesis of RF/RHD.